REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs | MicrobiomeTrials← Back to trialsNCT05622721
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-05-30Est. Completion: 2026-09-01
Enrollment target: 200 participants Locations- The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
DysbiosisCardiometabolic Health Indicators
This 8-week parallel-arm randomized controlled trial (N=70; ages 6-13) will determine the impact of daily almond butter …
Tallahassee, United StatesEst. completion Aug 31, 2028
COVID-19
Type I interferon (IFN-I) production is triggered by the detection of viral molecules, such as strands of viral RNA or D…
Lyon, FranceEst. completion Jun 2027
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative SyndromeHodgkin LymphomaLymphoma, Non-HodgkinMyelomaChronic Lymphocytic Leukemia
The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic h…
Amiens, FranceEst. completion May 2030